COMMUNIQUÉS West-GlobeNewswire

Guardant Health to Report Second Quarter 2019 Financial Results on August 6, 2019
01/08/2019
REDWOOD CITY, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the second quarter 2019 after market close on Tuesday, August 6, 2019. [...]
Menlo Therapeutics Reports Second Quarter 2019 Financial Results and Provides Program Updates Including Accelerated Timeline for Upcoming Clinical Data
01/08/2019
Results from Serlopitant Phase 2 Clinical Trial for the Treatment of Chronic Pruritus of Unknown Origin Anticipated in Q1 2020 Results from Serlopitant Phase 3 Clinical Trials for the Treatment of Pruritus with Prurigo [...]
Aduro Biotech Provides Business Update and Reports Second Quarter 2019 Financial Results
01/08/2019
BERKELEY, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and [...]
Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months Ended June 30, 2019
01/08/2019
Reaffirms full year 2019 financial forecast and operational goals Provides Q3 2019 revenue forecast of $245M-$275M GAITHERSBURG, Md., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported [...]
SeaSpine Reports Second Quarter 2019 Financial Results
01/08/2019
Increases 2019 Financial Outlook CARLSBAD, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of [...]
Momenta Pharmaceuticals Launches Phase 2/3 Trial of M281 for the Treatment of Warm Autoimmune Hemolytic Anemia and is Granted FDA Fast Track Designation
01/08/2019
CAMBRIDGE, Mass., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]
Geron Corporation Reports Second Quarter 2019 Financial Results and Recent Events
01/08/2019
MENLO PARK, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the second quarter ended June 30, 2019, and recent events. The Company ended the second quarter [...]
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
01/08/2019
PRINCETON, N.J., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common stock in an underwritten [...]
Iovance Biotherapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
01/08/2019
- Regulatory submission for LN-145 in advanced cervical cancer expected in the second half of 2020 - - Company to host conference call at 4:30 p.m. EDT today - SAN CARLOS, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- [...]
CareDx Reports Second Quarter 2019 Results
01/08/2019
AlloSure momentum drives 76% second quarter revenue growth BRISBANE, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a leading precision medicine company focused on the discovery, development and [...]
Jonathan Day Named VP, Commercial Operations, Americas
01/08/2019
Seasoned Commercial Leader with Track Record in Life Sciences and Diagnostics SOUTH SAN FRANCISCO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Jonathan [...]
Fulcrum Therapeutics to Present at the SVB Leerink Spotlight Series: Rare & Genetic Diseases Conference
01/08/2019
CAMBRIDGE, Mass., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq:FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in [...]
Oncternal Therapeutics to Report Second Quarter 2019 Financial Results and Provide Business Update
01/08/2019
SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biotechnology company developing potential first-in-class product candidates for cancers with critical unmet [...]
Ultragenyx Reports Second Quarter 2019 Financial Results and Corporate Update
01/08/2019
Strong Crysvita® (burosumab) Launch Continues with Approximately 960 Patients on Reimbursed Commercial Therapy in the United States Ultragenyx Submits New Drug Application to FDA for UX007 (triheptanoin) for Treatment [...]
Adverum Biotechnologies Announces Board and Senior Management Changes
01/08/2019
-- Director and Co-founder Mitchell Finer, Ph.D. to Retire for New Industry Role -- -- President, CSO Mehdi Gasmi, Ph.D. to Transition to Board of Directors -- -- Adverum Continues to Build Senior Team with Deep [...]
Atara Biotherapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Thursday, August 8, 2019
01/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Anne Myong Joins Align Technology Board of Directors
01/08/2019
SAN JOSE, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) announced today that it has appointed Anne Myong to its board of directors. Ms. Myong was previously Senior Vice President and [...]
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
01/08/2019
SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (“Arcturus” or the “Company”), a leading RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare [...]
Arcturus Therapeutics Receives up to $15 Million Commitment from the Cystic Fibrosis Foundation to Create mRNA Therapies to Treat Cystic Fibrosis Patients
01/08/2019
SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (“Arcturus” or the “Company”), a leading RNA medicines company, today announced that the Cystic Fibrosis Foundation (CF Foundation), has increased its [...]

Pages